We report the first multidrug-resistant Proteus mirabilis strain producing the carbapenemase OXA-48 (Pm-OXA-48) isolated at Al-Shifa hospital in Gaza, Palestine. Draft genome sequencing of Pm-OXA-48 identified 16 antimicrobial resistance genes, encoding resistance to ␤-lactams, aminoglycosides, fluoroquinolones, phenicols, streptothricin, tetracycline, and trimethoprimsulfamethoxazole. Complete sequencing of the bla OXA-48 -harboring plasmid revealed that it is a 72 kb long IncL/M plasmid, harboring carbapenemase gene bla OXA-48 , extended spectrum ␤-lactamase gene bla CTX-M-14 , and aminoglycoside resistance genes strA, strB, and aph(3=)-VIb.
C
arbapenemase-producing Enterobacteriaceae (CRE) have spread worldwide and caused a significant public health alert (1, 2) . However, our understanding of the dissemination of CRE in isolated regions, including the Palestinian territories, is limited. Here we report an OXA-48 type carbapenemase-producing Proteus mirabilis strain from Gaza, Palestine. OXA-48 was first identified in a Klebsiella pneumoniae strain isolated in Turkey in 2001 (3) . Recently, OXA-48 has been reported in a number of countries in Europe, North Africa, and the Middle East, and it is regarded as endemic in certain areas (1, 4) . bla has also been found in numerous other Enterobacteriaceae species, including Citrobacter freundii, Enterobacter spp., Escherichia coli, Klebsiella oxytoca, Providencia rettgeri, and Serratia marcescens (4) . Transmission of bla and other carbapenemase genes is of particular concern within bacterial species exhibiting intrinsic antibiotic resistance, such as P. mirabilis (intrinsically resistant to tetracyclines and polymyxins), as it can lead to the emergence of extensively drugresistant or pan-drug-resistant strains, further complicating clinical treatment. In this study, we used next-generation sequencing to characterize the genomes of the OXA-48-producing P. mirabilis strain (Pm-OXA-48) and the bla OXA-48 -harboring plasmid. To the best of our knowledge, this is the first genomic characterization of an OXA-48-type carbapenemase in P. mirabilis.
The P. mirabilis strain Pm-OXA-48 was isolated from a urine sample obtained from a female outpatient at Al-Shifa hospital, the largest medical complex and central hospital in Gaza, in April 2012. Previous travel history was not recorded. Susceptibility testing was performed by CLSI broth microdilution (5, 6) . The strain exhibited resistance or intermediate resistance to multiple antimicrobial agents, including cefotaxime (MIC, Ͼ32 g/ml), cefepime (MIC, Ͼ16 g/ml), ticarcillin-clavulanate (MICs, Ͼ128 and Ͼ2 g/ml, respectively), imipenem (MIC, Ͼ8 g/ml), doripenem (MIC, 2 g/ml), ciprofloxacin (MIC, Ͼ2 g/ml), levofloxacin (MIC, Ͼ8 g/ml), gentamicin (MIC, Ͼ8 g/ml), tobramycin (MIC, Ͼ8 g/ml), amikacin (MIC, Ͼ32 g/ml), minocycline (MIC, Ͼ16 g/ml), doxycycline (MIC, Ͼ16 g/ml), trimethoprim-sulfamethoxazole (MIC, Ͼ4 and Ͼ76 g/ml, respectively), colistin (MIC, Ͼ4 g/ml), polymyxin B (MIC, Ͼ4 g/ml), and tigecycline (MIC, Ͼ4 g/ml).
Whole genome sequencing of Pm-OXA-48 was performed using a MiSeq Desktop Sequencer (Illumina, San Diego, CA), and de novo assembly was performed using A5-miseq software (7) . The Pm-OXA-48 assembly resulted in 91 contigs, with an N50 contig size of 114,052 nucleotides, and a total length of 4,137,208 bp. The average GϩC content was 39.1%. Contigs were annotated using the Prokaryotic Genomes Automatic Annotation Pipeline available at NCBI (http://www.ncbi.nlm.nih.gov/genome/annotation _prok/), providing a total of 3,843 genes, 3,662 coding DNA sequence genes, 20 rRNAs (5S, 16S, and 23S), and 80 tRNAs.
Analyses of acquired antimicrobial resistance genes were performed using ResFinder 2.1 (8), while antibacterial biocide resistance and metal resistance were determined using the Antibacterial Biocide and Metal Resistance Genes Database (BacMet) (9) . This approach identified 16 antimicrobial resistance genes encoding resistance to ␤-lactams (bla , bla CTX-M-14 , and bla TEM-1 ), aminoglycosides [aph(3=)-Ia, aadA1, aac(3)-IIa, aph(3=)-VIb, strA, and strB], fluoroquinolones (qnrD), streptothricin (sat-1), phenicols (catA1 and cat), tetracycline [tet(J)], sulfonamide-trimethoprim (sul2 and dfrA1), and 27 genes related to antiseptic and toxic compound resistance, including arsR (arsenic resistance), cutEF (copper resistance), merA (mercury resistance), and emrD (benzalkonium resistance).
The quinolone resistance-determining region (QRDR) genes gyrA, gyrB, parC, and parE were further examined, and we observed mutations encoding amino acid substitutions at Ser83-Ile and Ser84-Arg within the QRDRs of GyrA and ParC, respectively. These genetic changes within Pm-OXA-48 correlated with the ciprofloxacin and levofloxacin resistance observed during susceptibility testing. In silico detection and typing of plasmids were performed using PlasmidFinder (10); three plasmid groups were identified in Pm-OXA-48, belonging to incompatibility groups L/M, Q1, and Col3M.
Unlike the spread of KPC-type carbapenemases, which are mainly associated with the clonal spread of K. pneumoniae sequence type 258 (ST258) strains (2), dissemination of OXA-48 is mainly associated with the horizontal transfer of a single IncL/M plasmid, pOXA-48a (4), although bla OXA-48 has also been reported in plasmids of other incompatibility groups (11) . In order to further characterize the novel bla OXA-48 -harboring plasmid from P. mirabilis strain Pm-OXA-48, we transferred it via conjugation to a recipient E. coli J53Az-resistant strain (12) . The E. coli J53 transconjugant of Pm-OXA-48 displayed reduced susceptibility to cefotaxime (MIC, Ͼ32 g/ml), cefepime (MIC, 16 g/ml), ticarcillin-clavulanate (MIC, Ͼ128 and Ͼ2 g/ml, respectively), imipenem (MIC, 2 g/ml), doripenem (MIC, 1 g/ml), tobramycin (MIC, 8 g/ml), and amikacin (MIC, Ͼ32 g/ml) but maintained susceptibility to minocycline (MIC, Յ2 g/ml), doxycycline (MIC, Յ2 g/ml), gentamicin (MIC, 4 g/ml), trimethoprimsulfamethoxazole (MIC, Յ1 and Յ19 g/ml, respectively), colistin (MIC, 0.5 g/ml), polymyxin B (MIC, 1 g/ml), and tigecycline (MIC, Յ0.25 g/ml) (5, 6).
Plasmid DNA from the E. coli J53 transconjugant harboring a single plasmid (subsequently named pOXA48-PM) was extracted using a Qiagen Plasmid Midi kit (Qiagen, Valencia, CA) and sequenced using the Illumina MiSeq system as described above (13) . Sequencing reads were assembled de novo, gaps were closed, and annotations were performed as described previously (13) . pOXA48-PM is 72,127 bp in length with an average GϩC content of 50.7%, significantly higher than that of the genome (39.1%), harbors 91 predicted open reading frames (ORFs), and belongs to the IncL/M incompatibility group (Fig. 1) . A BLAST search against all completely sequenced bla OXA-48 -harboring plasmids in GenBank (http://www.ncbi.nlm.nih.gov/GenBank/) indicated that pOXA48-PM is closely related to other bla OXA-48 -harboring IncL/M plasmids, including pOXA-48 (14), pKPoxa-48N1 (15), and pJEG011 (16) (Fig. 1) . It displayed the highest query coverage (97%) and overall nucleotide identity (99%) to pJEG011, a bla OXA-48 -harboring IncL/M plasmid from a K. pneumoniae ST101 strain (Kp002) isolated in Australia (16) .
The main difference between plasmids pOXA48-PM and pJEG011 is that their respective bla OXA-48 genes are carried on different Tn1999 elements. While bla OXA-48 was initially identified on composite transposon Tn1999.1 flanked by two copies of insertion sequence IS1999 (14) , three additional Tn1999 variants have since been reported (3, (17) (18) (19) (20) within the same conjugative plasmid also highlights the propensity of a highly transmissible plasmid capable of hydrolyzing all available ␤-lactams. In summary, this study describes the first report of a carbapenemase-producing Enterobacteriaceae strain in Gaza, Palestine, a highly populated region with poor public services and limited medical resources. To the best of our knowledge, it is also the first description of bla in Proteus spp. The pan-resistant nature of P. mirabilis strain Pm-OXA-48 underlies the significance of detection and mitigation of OXA-48 and other carbapenemases in this resource-poor region of the world before either the strains or the plasmids have the opportunity to spread further.
Nucleotide sequence accession numbers. The draft genome sequence of P. mirabilis strain Pm-OXA-48 has been deposited in the GenBank whole-genome shotgun (WGS) database under the accession no. JSCB00000000. The complete nucleotide sequence of plasmid pOXA48-PM has been deposited under the GenBank accession no. KP025948.
